Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
August 19, 2015Ophthalmology and TherapyOpen Access

The Future of Dry Eye Treatment: A Glance into the Therapeutic Pipeline

View Full Paper
Ask AI
Bookmark
Share

Authors

LVLaura VickersPGPreeya K. Gupta

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Vickers et al. (2015) studied this question.

synapsesocial.com/papers/6a6cfefca528af2d65c2930ehttps://doi.org/10.1007/s40123-015-0038-y
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Rebamipide Increases the Amount of Mucin-like Substances on the Conjunctiva and Cornea in the N-Acetylcysteine-Treated In Vivo Model2004 · 132 citations
  2. 2Rapid transport of large polymeric nanoparticles in fresh undiluted human mucus2007 · 1,045 citations
  3. 3Development of Sustained-Release Microspheres for the Delivery of SAR 1118, an LFA-1 Antagonist Intended for the Treatment of Vascular Complications of the Eye2012 · 18 citations
  4. 4Prevalence of and Risk Factors for Dry Eye Syndrome2000 · 1,230 citations
  5. 5Design of a superior cytokine antagonist for topical ophthalmic use2013 · 60 citations